Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for reduction of postoperative bleeding in open heart surgery
IRCT20200424047185N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desmopressin in postoperative hemorrhage (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Postoperative bleeding. Started Mar 2020; status: completed.
02
Drugs
desmopressin
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on IRCT20200424047185N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200424047185N1.